AAAAAA
Results:
1-23
|
Results: 23
Authors:
LILLEY GG
BARBOSA JARG
PEARCE LA
Citation: Gg. Lilley et al., EXPRESSION IN ESCHERICHIA-COLI OF THE PUTATIVE N-ACETYLNEURAMINATE LYASE GENE (NANA) FROM HAEMOPHILUS-INFLUENZAE - OVERPRODUCTION, PURIFICATION, AND CRYSTALLIZATION, Protein expression and purification, 12(3), 1998, pp. 295-304
Authors:
ZABALGOITIA M
HALPERIN JL
PEARCE LA
BLACKSHEAR JL
ASINGER RW
HART RG
Citation: M. Zabalgoitia et al., TRANSESOPHAGEAL ECHOCARDIOGRAPHIC CORRELATES OF CLINICAL RISK OF THROMBOEMBOLISM IN NONVALVULAR ATRIAL-FIBRILLATION, Journal of the American College of Cardiology, 31(7), 1998, pp. 1622-1626
Authors:
ANDERSON DC
HALPERIN JL
HART RG
MCANULTY JH
MCBRIDE R
PEARCE LA
SHERMAN DG
Citation: Dc. Anderson et al., PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION AT LOW-RISK OF STROKE DURING TREATMENT WITH ASPIRIN - STROKE PREVENTION IN ATRIAL-FIBRILLATION III STUDY, JAMA, the journal of the American Medical Association, 279(16), 1998, pp. 1273-1277
Authors:
BLACKSHEAR JL
PEARCE LA
HART RG
Citation: Jl. Blackshear et al., PREDICTORS OF AORTIC PLAQUE AND COMPLEX PLAQUE IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION (SPAF)-III STUDY, Circulation, 98(17), 1998, pp. 511-511
Authors:
BLACKSHEAR JL
PEARCE LA
ZABALGOITIA M
Citation: Jl. Blackshear et al., LOW-RISK OF CHOLESTEROL CRYSTAL EMBOLIZATION (CCE) DURING WARFARIN THERAPY IN PATIENTS WITH AORTIC PLAQUE (AP), Circulation, 98(17), 1998, pp. 514-514
Authors:
BLACKSHEAR JL
PEARCE LA
REDFIELD MM
Citation: Jl. Blackshear et al., IS BRAIN NATRIURETIC PEPTIDE (BNP) A MARKER FOR PROGNOSIS IN CHRONIC ATRIAL-FIBRILLATION (AF), Circulation, 98(17), 1998, pp. 1159-1159
Authors:
ZABALGOITIA M
LEONARD A
BLACKSHEAR JL
SAFFORD R
BAKER VS
FENSTER P
PENNOCK GD
OHM J
HUERTA BJ
STRAUSS R
MCKENZIE M
HARTMCARTHUR P
GRAMBERG M
HOUSTON H
CHAN KL
BIGGS J
IVES A
ROTHBART R
MURRAY D
LOUTFI H
LYNCH JJ
CARLSON L
LABOVITZ AJ
VIGIL A
ASINGER RW
DICK CD
NEWBURG SM
FIFIELD J
KHANDHERIA BK
HOLLAND AE
TUCKER KR
GOLDMAN ME
ROTHLAUF EB
HESS D
YOUNG L
MEGO DM
BOYD S
WILSON D
NOLTE B
EDWARDS C
MEZEI L
RIGGIO S
GIRAUD G
MARCHANT C
TIMBERG J
DITTRICH HC
KEEN W
KERRIDGE C
BERNARD S
BATTINELLI N
ATWOOD JE
QUAGLIETTI S
ALPERT MA
MASSEY CV
HUPP C
KOEHLER J
PEARCE LA
HALPERIN JL
HART RG
MARLER JR
DEMARIA AN
TAJIK AJ
WEYMAN A
Citation: M. Zabalgoitia et al., TRANSESOPHAGEAL ECHOCARDIOGRAPHIC CORRELATES OF THROMBOEMBOLISM IN HIGH-RISK PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION, Annals of internal medicine, 128(8), 1998, pp. 639
Authors:
PEARCE LA
ODDIE GW
COIA G
KORTT AA
HUDSON PJ
LILLEY GG
Citation: La. Pearce et al., LINEAR GENE FUSIONS OF ANTIBODY FRAGMENTS WITH STREPTAVIDIN CAN BE LINKED TO BIOTIN-LABELED SECONDARY MOLECULES TO FORM BISPECIFIC REAGENTS, Biochemistry and molecular biology international, 42(6), 1997, pp. 1179-1188
Authors:
KORTT AA
LAH M
ODDIE GW
GRUEN CL
BURNS JE
PEARCE LA
ATWELL JL
MCCOY AJ
HOWLETT GJ
METZGER DW
WEBSTER RG
HUDSON PJ
Citation: Aa. Kortt et al., SINGLE-CHAIN FV FRAGMENTS OF ANTI-NEURAMINIDASE ANTIBODY NC10 CONTAINING 5-RESIDUE AND 10-RESIDUE LINKERS FORM DIMERS AND WITH ZERO-RESIDUELINKER A TRIMER, Protein engineering, 10(4), 1997, pp. 423-433
Authors:
FEINBERG WM
CORNELL ES
NIGHTINGALE SD
PEARCE LA
TRACY PT
HART RG
BOVILL EG
Citation: Wm. Feinberg et al., RELATIONSHIP BETWEEN PROTHROMBIN ACTIVATION FRAGMENT F1.2 AND INTERNATIONAL NORMALIZED RATIO IN PATIENTS WITH ATRIAL-FIBRILLATION, Stroke, 28(6), 1997, pp. 1101-1106
Authors:
FEINBERG WM
MACY EM
NIGHTINGALE SD
CORNELL ES
PEARCE LA
BOVILL EG
Citation: Wm. Feinberg et al., PLASMIN-ALPHA(2) ANTIPLASMIN LEVELS IN PATIENTS WITH ATRIAL-FIBRILLATION, Stroke, 28(1), 1997, pp. 54-54
Authors:
ATWELL JL
PEARCE LA
LAH M
GRUEN LC
KORTT AA
HUDSON PJ
Citation: Jl. Atwell et al., DESIGN AND EXPRESSION OF A STABLE BISPECIFIC SCFV DIMER WITH AFFINITYFOR BOTH GLYCOPHORIN AND N9 NEURAMINIDASE, Molecular immunology, 33(17-18), 1996, pp. 1301-1312
Authors:
BLACKSHEAR JL
SAFFORD RE
PEARCE LA
Citation: Jl. Blackshear et al., F-AMPLITUDE, LEFT ATRIAL APPENDAGE VELOCITY, AND THROMBOEMBOLIC RISK IN NONRHEUMATIC ATRIAL-FIBRILLATION, Clinical cardiology, 19(4), 1996, pp. 309-313
Authors:
MILLER VT
PEARCE LA
FEINBERG WM
ROTHROCK JF
ANDERSON DC
HART RG
Citation: Vt. Miller et al., DIFFERENTIAL EFFECT OF ASPIRIN VERSUS WARFARIN ON CLINICAL STROKE TYPES IN PATIENTS WITH ATRIAL-FIBRILLATION, Neurology, 46(1), 1996, pp. 238-240
Authors:
FEINBERG WM
MILLER VT
ROTHROCK JF
HART RG
PEARCE LA
Citation: Wm. Feinberg et al., DIFFERENTIAL EFFECT OF ASPIRIN AND WARFARIN ON STROKE SUBTYPES IN PATIENTS WITH ATRIAL-FIBRILLATION, Stroke, 26(1), 1995, pp. 185-185
Authors:
BLACKSHEAR JL
SAFFORD RE
PEARCE LA
Citation: Jl. Blackshear et al., COARSENESS OF NONRHEUMATIC ATRIAL-FIBRILLATION - AN ANALYSIS OF 464 PATIENTS FOLLOWED FOR 1.3 YEARS, Journal of the American College of Cardiology, 1994, pp. 10000253-10000253
Authors:
MCBRIDE R
CHESEBRO JH
WIEBERS DO
HOLLAND AE
LINKER S
BARDSLEY WT
KOPECKY S
LITIN SC
MEISSNER I
ZERBE DM
FLAKER GC
WEBEL R
NOLTE B
STEVENSON P
BYER J
JENKINS JS
WRIGHT W
ANDERSON DC
ASINGER RW
NEWBURG SM
BUNDLIE SR
FARMER CC
KOLLER RL
HAUGLAND JM
NANCE MA
TARREL RM
DUNBAR DN
JORGENSEN CR
SHARKEY SW
LEONARD ADS
KANTER MC
SOLOMON DH
ZABALGOITIA M
MCANULTY JH
MARCHANT C
COULL BM
KELLEY RE
CHAHINE R
PALERMO M
TEIXEIRO P
FELDMAN G
HAYWARD A
MACMILLAN K
GANDARA E
ANDERSON W
BLANK N
STRAUSS R
FEINBERG WM
VOLD BK
KERN KB
APPLETON C
BRUCK D
DORR S
DITTRICH HC
ROTHROCK JF
KERRIDGE C
LOGAN WR
HAMILTON WP
GREEN BJ
BACON RS
HELGASON CM
KONDOS GT
HOFF J
MCRAE RP
HALPERIN JL
ROTHLAUF EB
WEINBERGER JM
GOLDMAN ME
MILLER VT
HOCKERSMITH CJ
COHEN BA
JANOSIK DL
CADELL DJ
KELLERMAN L
GOMEZ CR
LABOVITZ AJ
ROTHBART RM
BAILEY GH
BURKHARDT C
HORWITZ L
BLACKSHEAR JL
WEAVER L
BAKER V
LEE G
LANE G
RUBINO F
SAFFORD R
KRONMAL RA
PEARCE LA
FLETCHER KA
NASCO E
HART RG
SHERMAN DG
TALBERT RL
DACY TL
HERBERLING PA
Citation: R. Mcbride et al., WARFARIN VERSUS ASPIRIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-II STUDY, Lancet, 343(8899), 1994, pp. 687-691
Authors:
HART RG
PEARCE LA
HALPERIN JL
MILLER VT
Citation: Rg. Hart et al., ASPIRIN IN ELDERLY ATRIAL-FIBRILLATION PATIENTS, Stroke, 25(7), 1994, pp. 1525-1526
Authors:
KANTER MC
TEGELER CH
PEARCE LA
WEINBERGER J
FEINBERG WM
ANDERSON DC
GOMEZ CR
ROTHROCK JF
HELGASON CM
HART RG
Citation: Mc. Kanter et al., CAROTID STENOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION - PREVALENCE, RISK-FACTORS, AND RELATIONSHIP TO STROKE IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY, Archives of internal medicine, 154(12), 1994, pp. 1372-1377
Authors:
HESS JC
SEDGHINASAB M
MOE RE
PEARCE LA
TAPPER D
Citation: Jc. Hess et al., GROWTH-FACTOR PROFILES IN BREAST CYST FLUID IDENTIFY WOMEN WITH INCREASED BREAST-CANCER RISK, The American journal of surgery, 167(5), 1994, pp. 523-530
Authors:
WEINBERGER J
KANTER MC
PEARCE LA
Citation: J. Weinberger et al., CAROTID STENOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION - PREVALENCE AND RISK-FACTORS IN THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY, Neurology, 43(4), 1993, pp. 390-390
Authors:
MCANULTY JH
HART RG
PEARCE LA
Citation: Jh. Mcanulty et al., ATRIAL-FIBRILLATION AND THROMBOEMBOLISM - PREDICTORS OF HIGH-RISK DURING ASPIRIN THERAPY, Circulation, 88(4), 1993, pp. 222-222
Authors:
BLACKSHEAR JL
PEARCE LA
ASINGER RW
DITTRICH HC
GOLDMAN ME
ZABALGOITIA M
ROTHBART RM
HALPERIN JL
Citation: Jl. Blackshear et al., MITRAL REGURGITATION ASSOCIATED WITH REDUCED THROMBOEMBOLIC EVENTS INHIGH-RISK PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION, The American journal of cardiology, 72(11), 1993, pp. 840-843
Risultati:
1-23
|